Prof. Dr. Cemşid Demiroğlu


Prof. Cemşid Demiroğlu, M.D., is President and Chief Executive Officer of Group Florence Nightingale Hospitals.
Dr. Demiroğlu first joined GFNH in 1993. As CEO, Dr. Demiroğlu presides a 700 bed capacity healthcare system comprised of four hospitals and two medical centers one of them being in London, United Kingdom.

Under his leadership, GFNH has consistently expanded and is considered as one of the leading healthcare groups not only in Turkey and also in the region. In 2006 he established the first medical university namely Istanbul Bilim University where 3000 students are enrolled. |

Education & Fellowships

1987-1991 Residency - Istanbul University Institute of Cardiology Istanbul, Turkey
1980-1987 Medical School - Istanbul University Cerrahpaşa Medical School Istanbul, Turkey
1974-1980 Undergraduate - Saint Michel French High School Istanbul, Turkey


Interventional Cardiology


2000 Professor of Cardiology Kadir Has University Medical Faculty Istanbul, Turkey
1993 Associate Professor Istanbul University Institute of Cardiology Istanbul, Turkey
1991-1992 Fellow St. Thomas Hospital London, UK
1991-1993 Assistant Professor Istanbul University Institute of Cardiology Istanbul, Turkey
Fellow Arizona Heart Institute Phoenix, ABD

Administrative Positions

2002 President & CEO Group Florence Nightingale Hospitals
2006 President Istanbul Bilim University
2000-2002 Vice President & CEO Group Florence Nightingale Hospitals
1995-2000 Executive Board Member Group Florence Nightingale Hospitals

Research & Publications

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Group Florence Nightingale Hospitals.)

Comparison of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention.
Erdim R, Erciyes D, Görmez S, Karabay KO, Catakoğlu AB, Aytekin V, Demiroğlu C, Gülbaran M.
Anadolu Kardiyol Derg. 2010 Aug;10(4):340-5. doi: 10.5152/akd.2010.093.
PMID:20693130 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

Treatment of saphenous vein graft lesions with paclitaxel- and sirolimus-eluting stents: comparison of short- and long-term clinical outcomes.
Görmez S, Erdim R, Erdoğmuş O, Civan M, Catakoğlu AB, Gülbaran M, Demiroğlu C, Aytekin V.
Anadolu Kardiyol Derg. 2008 Dec;8(6):431-6.
PMID:19103539 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

Thrombosed giant right coronary artery aneurysm.
Celebi H, Duran C, Catakoglu AB, Gülbaran M, Demiroglu C, Aytekin V.
Anadolu Kardiyol Derg. 2007 Sep;7(3):350-1. No abstract available.
PMID:17785248 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

[The effects of phase II cardiac rehabilitation programme on patients undergone coronary bypass surgery].
Ciftçi C, Duman BS, Cağatay P, Demiroğlu C, Aytekin V.
Anadolu Kardiyol Derg. 2005 Jun;5(2):116-21. Turkish.
PMID:15939686    [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

Very late thrombosis of paclitaxel-eluting stent.
Aytekin V, Erdim R, Gormez S, Demiroglu C.
Cardiovasc Revasc Med. 2008 Oct-Dec;9(4):275-7.
PMID: 18928954 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries.
Celebi H, Catakoglu AB, Kurtoglu H, Sener M, Hanavdelogullari R, Demiroglu C, Aytekin V, Aytekin S.
Cardiovasc Revasc Med. 2008 Jul-Sep;9(3):144-8.
PMID: 18606377 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

Aneurysm of the membranous septum detected during left ventriculography and demonstrated by cardiac magnetic resonance imaging.
Catakoglu AB, Aytekin V, Aytekin S, Duran C, Polat B, Demiroglu C.
Int J Cardiol. 2009 Aug 21;136(3):e60-2. Epub 2008 Jul 31. No abstract available.
PMID: 18674835 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty.
Sirikci O, Aytekin V, Demiroglu IC, Demiroglu C, Marcovina SM.
Int J Clin Lab Res. 2000;30(2):93-9.
PMID: 11043503 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu

The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
Duman BS, Turkoglu C, Gunay D, Cagatay P, Demiroglu C, Buyukdevrim AS.
Diabetes Nutr Metab. 2003 Aug;16(4):243-50.
PMID: 14768774 [PubMed - indexed for MEDLINE] Cemşid Demiroğlu